Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition : The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations

Bex, Axel ; Albiges, Laurence ; Staehler, Michael ; Bensalah, Karim ; Giles, Rachel H. ; Dabestani, Saeed LU ; Hofmann, Fabian ; Hora, Milan ; Kuczyk, Markus A. and Lam, Thomas B. , et al. (2018) In European Urology 74(6). p.849-851
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
European Urology
volume
74
issue
6
pages
3 pages
publisher
Elsevier
external identifiers
  • scopus:85056208512
  • pmid:30201510
ISSN
0302-2838
DOI
10.1016/j.eururo.2018.08.029
language
English
LU publication?
yes
id
dc34d3e4-5be5-497a-a6fe-5d2ea69e6b53
date added to LUP
2018-11-21 13:21:07
date last changed
2024-01-30 03:04:08
@article{dc34d3e4-5be5-497a-a6fe-5d2ea69e6b53,
  author       = {{Bex, Axel and Albiges, Laurence and Staehler, Michael and Bensalah, Karim and Giles, Rachel H. and Dabestani, Saeed and Hofmann, Fabian and Hora, Milan and Kuczyk, Markus A. and Lam, Thomas B. and Marconi, Lorenzo and Merseburger, Axel S. and Fernández-Pello, Sergio and Tahbaz, Rana and Abu-Ghanem, Yasmin and Volpe, Alessandro and Ljungberg, Börje and Escudier, Bernard and Powles, Thomas}},
  issn         = {{0302-2838}},
  language     = {{eng}},
  number       = {{6}},
  pages        = {{849--851}},
  publisher    = {{Elsevier}},
  series       = {{European Urology}},
  title        = {{A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition : The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations}},
  url          = {{http://dx.doi.org/10.1016/j.eururo.2018.08.029}},
  doi          = {{10.1016/j.eururo.2018.08.029}},
  volume       = {{74}},
  year         = {{2018}},
}